Overstressed
Senior Member
- Messages
- 406
- Location
- Belgium
Hi,
I've found this:
"Dear Prof. Ruggiero,
How do you explain that ComputerGeek who now tests nagalese at 0.70 after 18 shots of nagalese reports this?:
"Re: Yamamoto's GcMAF clinical trials
Received my orthodox clinical markers today. CD4 declined to 230 (from 400 the previous test in June) and VL was 27.5k. The orthodox doctor, naturally, increased the pressure to start on ARVs as soon as possible to prevent the very real risk of complications."
I guess we are all disappointed by those results.
There is a guy in New Zealand that reported big rise in his CD4 after just 8 shots but administered in IV injections.
Shouldn't IV be more efficient? If yes, can I use the same insulin seringe?
Thx.
TS"
on: http://forums.questioningaids.com/showthread.php?t=7588&page=3
This person(HIV+) reports a decline in his CD4-cells, and a viral load of 27.5K - This experience is frightening, because his Nagalase declined to 0.7, and yet, still he has a viral load that is quite high. Also, his immune cells declined, which is a very bad thing when you're HIV+.
I'm puzzled, because this is so contradictionary to Yamamoto's paper, he reported no measurable viral load when Nagalase was in the healthy range(i.e. 0.7 = healthy).
Is this the difference between responders and non-responders ? It would mean that Nagalase drops in any case, and is no good biomarker.
Questions, questions, questions...
I've found this:
"Dear Prof. Ruggiero,
How do you explain that ComputerGeek who now tests nagalese at 0.70 after 18 shots of nagalese reports this?:
"Re: Yamamoto's GcMAF clinical trials
Received my orthodox clinical markers today. CD4 declined to 230 (from 400 the previous test in June) and VL was 27.5k. The orthodox doctor, naturally, increased the pressure to start on ARVs as soon as possible to prevent the very real risk of complications."
I guess we are all disappointed by those results.
There is a guy in New Zealand that reported big rise in his CD4 after just 8 shots but administered in IV injections.
Shouldn't IV be more efficient? If yes, can I use the same insulin seringe?
Thx.
TS"
on: http://forums.questioningaids.com/showthread.php?t=7588&page=3
This person(HIV+) reports a decline in his CD4-cells, and a viral load of 27.5K - This experience is frightening, because his Nagalase declined to 0.7, and yet, still he has a viral load that is quite high. Also, his immune cells declined, which is a very bad thing when you're HIV+.
I'm puzzled, because this is so contradictionary to Yamamoto's paper, he reported no measurable viral load when Nagalase was in the healthy range(i.e. 0.7 = healthy).
Is this the difference between responders and non-responders ? It would mean that Nagalase drops in any case, and is no good biomarker.
Questions, questions, questions...